Guanylyl Imidodiphosphate (lithium salt)
(Synonyms: Gpp(NH)p lithium) 目录号 : GC43798Guanylyl Imidodiphosphate (lithium salt)是一种稳定的GTP类似物,是腺苷酸环化酶的有效激活剂。
Cas No.:64564-03-0
Sample solution is provided at 25 µL, 10mM.
Guanylyl Imidodiphosphate (lithium salt), a stable GTP analog, is a potent activator of adenylate cyclase[1]. Guanylyl Imidodiphosphate reduces the binding of agonist ligands (±)-[3H]epinephrine and (-)-[3H]norepinephrine to α-noradrenergic receptors in calf frontal cerebral cortex membranes, exhibiting IC50 values with 1-10μM[1]. Guanylyl Imidodiphosphate selectively and potently inhibits the high-affinity binding of the tritiated agonist with an IC50 value of 0.1µM[2-3].
In vitro, Guanylyl Imidodiphosphate and GTP significantly enhanced enzymatic activity of adenylate cyclase (EC4.6.1.1) in the renal plasma membranes of male Ranger strain chicks (Ross Poultry, Worcester)[4-5]. Guanylyl Imidodiphosphate, with EC50 achieved at 3.1μM concentration after 12min incubation, produced an 8.2-fold (720%) enhancement in enzymatic activity of adenylate cyclase relative to basal levels[5]. Guanylyl Imidodiphosphate demonstrated dose-dependent inhibition of nuclear membrane assembly in Xenopus egg extracts, at a concentration of 3mM, Guanylyl Imidodiphosphate completely blocked both vesicle fusion and nuclear envelope formation throughout the 160 minutes. When applied at 1mM concentration, Guanylyl Imidodiphosphate delayed the initiation of vesicle fusion by 80 minutes post-cytosol addition and significantly suppressed nuclear envelope expansion, reducing the growth rate of nuclear envelope by more than 6-fold[6].
References:
[1] U'Prichard D C, Snyder S H. Guanyl nucleotide influences on 3H-ligand binding to α-noradrenergic receptors in calf brain membranes[J]. Journal of Biological Chemistry, 1978, 253(10): 3444-3452.
[2] Mollereau C, Pascaud A, Baillat G, et al. 5′-Guanylylimidodiphosphate decreases affinity for agonists and apparent molecular size of a frog brain opioid receptor in digitonin solution[J]. Journal of Biological Chemistry, 1988, 263(34): 18003-18008.
[3] Roy C, LE BARS N C, JARD S. Vasopressin‐Sensitive Kidney Adenylate Cyclase: Differential Effects of Monovalent Ions on Stimulation by Fluoride, Vasopressin and Guanylyl 5′‐imidodiphosphate[J]. European Journal of Biochemistry, 1977, 78(2): 325-332.
[4] ABOU-ISSA H, REICHERT JR L E O E. Modulation of follicle-stimulating hormone-sensitive rat testicular adenylate cyclase activity by guanyl nucleotides[J]. Endocrinology, 1979, 104(1): 189-193.
[5] Hunt N H, Martin T J, Michelangeli V P, et al. Effect of guanyl nucleotides on parathyroid hormone-responsive adenylate cyclase in chick kidney[J]. Journal of Endocrinology, 1976, 69(3): 401-412.
[6] Boman A L, Delannoy M R, Wilson K L. GTP hydrolysis is required for vesicle fusion during nuclear envelope assembly in vitro[J]. The Journal of cell biology, 1992, 116(2): 281-294.
Guanylyl Imidodiphosphate (lithium salt)是一种稳定的GTP类似物,是腺苷酸环化酶的有效激活剂。Guanylyl Imidodiphosphate能够减少激动剂配体(±)-[3H]肾上腺素和(-)-[3H]去甲肾上腺素与牛额叶大脑皮层膜中α-去甲肾上腺素受体的结合,IC50值范围为1-10μM[1]。Guanylyl Imidodiphosphate选择性且有效地抑制高亲和力的氚化激动剂结合,IC50值为0.1µM[2-3]。
在体外,Guanylyl Imidodiphosphate (lithium salt)和GTP显著增强了雄性Ranger品系雏鸡(Ross Poultry, Worcester)肾血浆膜中腺苷酸环化酶(EC4.6.1.1)的酶活性[4-5]。Guanylyl Imidodiphosphate在12分钟孵育后达到EC50的浓度为3.1μM,使酶活性相对于基础水平提高了8.2倍(720%)[5]。Guanylyl Imidodiphosphate在非洲爪蟾卵提取物中表现出剂量依赖性的核膜组装抑制作用,在3mM浓度下,Guanylyl Imidodiphosphate在160分钟内完全阻断了囊泡融合和核膜的形成。当浓度为1mM时,Guanylyl Imidodiphosphate将囊泡融合的起始时间延迟了80分钟,并显著抑制了核膜的扩张,将核膜生长速率降低了6倍以上[6]。
Cell experiment [1]: | |
Cell lines | Xenopus egg cells |
Preparation Method | Xenopus egg extracts were prepared through sequential centrifugation steps to isolate cytosolic and membrane fractions. Initially, dejellied Xenopus eggs were subjected to low-speed centrifugation (10000g, 12min) to generate a crude cytoplasmic extract. The supernatant was then fractionated by ultracentrifugation (200000g, 1h, 4°C) to separate membrane and cytosolic components. The cytosolic fraction underwent additional clarification (200000g, 25min) and was supplemented with an ATP-regenerating system (1mM ATP, 50μg/ml creatine phosphokinase, 10mM creatine phosphate) before aliquoting and storage in liquid nitrogen (-80°C). The membrane fraction was purified through a sucrose cushion (1.3M sucrose, 26600g, 15min, 4°C) following dilution in membrane wash buffer (MWB), then resuspended in MWB containing 0.5M sucrose at a concentration equivalent to 10% of the cytosolic volume. Both fractions exhibited protein concentrations ranging from 25-35 mg/ml. For functional assays, thawed membrane fractions were incubated with cytosol and guanylyl imidodiphosphate (lithium salt) (0.1-3mM) for 30-180min at 23°C. Following pre-incubation, samples were diluted with MWB containing Guanylyl Imidodiphosphate (lithium salt) and pelleted (20000g, 15min, 4°C). The treated membranes were resuspended to their original volume in MWB, and 2μl aliquots were combined with 1μl swollen chromatin for 30 minutes binding. Membrane fusion activity was subsequently assessed by adding 20μl fresh cytosol to the reaction mixture. |
Reaction Conditions | 0.1, 1 and 3mM; 60, 120 and 180min |
Applications | Guanylyl Imidodiphosphate (lithium salt) significantly blocked both vesicle fusion and nuclear envelope formation. |
References: |
Cas No. | 64564-03-0 | SDF | |
别名 | Gpp(NH)p lithium | ||
化学名 | 5’-guanylic acid, monoanhydride with imidodiphosphoric acid, tetralithium salt | ||
Canonical SMILES | O[C@H]1[C@H](N2C=NC3=C2N=C(N)NC3=O)O[C@H](COP(OP(NP([O-])([O-])=O)([O-])=O)([O-])=O)[C@H]1O.[Li+].[Li+].[Li+].[Li+] | ||
分子式 | C10H13N6O13P3 • 4Li | 分子量 | 545.9 |
溶解度 | 10mg/mL in PBS, pH7.2 | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 1.8318 mL | 9.1592 mL | 18.3184 mL |
5 mM | 0.3664 mL | 1.8318 mL | 3.6637 mL |
10 mM | 0.1832 mL | 0.9159 mL | 1.8318 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >95.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet